Abdul Kader Mohiuddin*

Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh

*Corresponding Author: Abdul Kader Mohiuddin, Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh.

Received: November 03, 2022; Published: January 01, 2023

Abstract

Abbreviations

ADEs: Adverse Drug Events; NSAIDs: Non-Steroidal Anti-Inflammatory Drugs; CDC: The Centers for Disease Control and Prevention; WHO: World Health Organization

Keywords: Patient Compliance; Healthcare Denials; Medication Adherence; Elderly Patient Care; Treatment Failure

References

1. Grissinger M. “The Five Rights: A Destination Without a Map”. P T10 (2010): 542.
2. Brown MT and Bussell JK. “Medication adherence: WHO cares?” Mayo Clinic Proceedings 4 (2011): 304-314.
3. Center for Drug Evaluation and Research. (n.d.). “Why you need to take your medications as prescribed or instructed”. U.S. Food and Drug Administration (2022).
4. Barnett NL. “Medication adherence: where are we now? A UK perspective”. European Journal of Hospital Pharmacy: Science and Practice 21 (2014): 181-184.
5. Campbell Denis and Pamela Duncan. “Record 6.8m People Waiting for Hospital Treatment in England”. The Guardian, 8 Sept. (2022).
6. Andrews Luke. “60% of Patients Waiting 18 Wks for Treatment at Worst-performing Trust”. Mail Online, 7 Mar (2022).
7. Cutler RL., et al. “Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system”. Patient Prefer Adherence 13 (2019): 853-862.
8. Bonsu KO., et al. “Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey”. Patient Prefer Adherence 16 (2022): 1771-1780.
9. Furniss D., et al. “Unintentional non-adherence: can a spoon full of resilience help the medicine go down?” BMJ Quality Safety2 (2014): 95-98.
10. Bahta M., et al. “Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method”. PLoS One1 (2020): e0228013.
11. “Improve Antibiotic Use.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 9 Mar (2022).
12. Antimicrobial Resistance Collaborators. “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis”. Lancet10325 (2022): 629-655.
13. Kasciuškevičiūtė S., et al. “Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study”. Medicina (Kaunas) 54.2 (2018): 30.
14. Lucas GNC., et al. “Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs”. Brazilian Journal of Nephrology 1 (2019): 124-130.
15. Jahrami H., et al. “Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis”. Journal of Clinical Sleep Medicine 2 (2021): 299-313.
16. Ostuzzi G., et al. “Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations”. BMC Medicine1 (2000): 215.
17. Bhadelia A., et al. “Solving the Global Crisis in Access to Pain Relief: Lessons From Country Actions”. American Journal of Public Health1 (2019): 58-60.
18. Chauke GD., et al. “Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review”. Heliyon 6 (2022): e09716.
19. Chong E., et al. “Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with Type 2 diabetes mellitus: a population-based cohort study”. Diabetics Medicine (2014).
20. Sohal T., et al. “Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review”. PLoS One9 (2015): e0136202.
21. Félix IB and Henriques A. “Medication adherence and related determinants in older people with multimorbidity: a cross‐sectional study”. Nursing Forum 56 (2021): 834-843.
22. Chippa V and Roy K. “Geriatric Cognitive Decline and Polypharmacy”. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2022).
23. Varghese D., et al. “Polypharmacy”. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2022).
24. Choudhry NK., et al. “Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association”. Hypertension1 (2022): e1-e14.
25. Alsairafi ZK., et al. “Patients' management of type 2 diabetes in Middle Eastern countries: review of studies”. Patient Prefer Adherence 10 (2016): 1051-1062.
26. Lossius M I., et al. “Seponering av Antiepileptika Ved anfallsfrihet - når og hvordan?” Tidsskrift for Den Norske Legeforening6 (2017): 451-454.
27. Jin J., et al. “Factors affecting therapeutic compliance: A review from the patient's perspective”. Therapeutics and Clinical Risk Management1 (2008): 269-286.

Citation

Citation: Abdul Kader Mohiuddin. “Medication Adherence: Fact or Fictions?". Acta Scientific Pharmaceutical Sciences 7.2 (2023): 01-03.

Copyright

Copyright: © 2022 Abdul Kader Mohiuddin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.